Re:A New Look Inside Theranos’ Dysfunctional Corporate Culture
by tonyedgecombe on Tuesday May 22, 2018 @09:16AM
(#17125671)
I don't think it works that well in our industry either. Products from companies that follow that process are at best frustrating to work with because of the constant churn.
Balwani’s outlandish behavior aside, a lot of this stuff doesn’t seem all that bad, if this weren’t a medical product. Raising money for a product you’re not sure will work out, tinkering with what a competitor has done and seeing what you can borrow, launching without a credible fallback and just hoping for the best.
I think I’ve done all of these things, but for software that doesn’t put peoples lives on the line.